Flu News and Research

RSS

Notificateur communications tool: Preventive measure for influenza A virus

In preparation for the second wave of the influenza A (H1N1) virus, Hi-VOS proposes a fast and effective communications tool to help public institutions and businesses better communicate with various groups among the Canadian population: employees, parents, students and clients.

23 Oct 2009

Some hospital revenues could decline if H1N1 becomes pandemic

"While it's common for hospitals to see a revenue boost at the onset of seasonal influenza season, the additional threat of cases from the H1N1 swine flu virus could complicate this fall's and winter's financial picture for such health facilities," The Chicago Tribune reports.

23 Oct 2009

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.

23 Oct 2009

Majority of allergy patients can be vaccinated against swine flu after evaluation by an allergist

Once supply catches up with the immediate demand for H1N1 "swine" flu vaccine, some allergy patients who could benefit from the vaccine may needlessly avoid it due to confusion over who should, and should not, be vaccinated, cautions Dr. Peter R. Smith, a board-certified allergist and clinical immunologist with Allergy Partners of Fredericksburg, Virginia.

23 Oct 2009

45% of American adults not inclined to get vaccinated against seasonal flu

Two in five at-risk American adults who would benefit from vaccination against seasonal flu are missing out on the protective shots because they believe they do not need them and are not inclined to be vaccinated. And among those who say they do intend to take up the vaccine, nearly half get around to it, according to Dr. Katharine Harris from the RAND Corporation in Arlington, USA, and her team.

23 Oct 2009

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.

22 Oct 2009

eHealthInsurance releases answers for FAQs on swine flu and their health insurance

eHealthInsurance (NASDAQ: EHTH) today released a list of answers to questions frequently asked from people concerned about the H1N1 virus (also called swine flu) and their health insurance, who have called into its Customer Care Center, which includes a call center staffed with licensed insurance agents. Getting answers to these questions is particularly important for high-risk individuals: pregnant women, children and seniors.

22 Oct 2009

“Sid the Science Kid” show to explain the science behind flu vaccinations

Health and Human Services Secretary Kathleen Sebelius, Education Secretary Arne Duncan, and Lisa Henson, CEO of the Jim Henson Company, will join Washington-area school children for a screening of the new “Sid the Science Kid” special episode on the flu at the U.S. Department of Education Auditorium.

22 Oct 2009

Awareness campaign to educate families on H1N1 flu virus, seasonal flu and common cold

Dial Complete Antibacterial Foaming Hand Wash, the #1 doctor-recommended brand, today announced it is working together with other leading brands to raise awareness and educate families to ‘Plan, Prepare and Defend’ against the H1N1 flu virus, seasonal flu and the common cold.

22 Oct 2009

FDA uses Wolters Kluwer Pharma Solutions' prescription data for tracking viral treatments

Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, announced today that the Food and Drug Administration (FDA) is using its prescription data to track the treatment of H1N1 and other influenza viruses.

22 Oct 2009

CDC urges heart disease patients get vaccinated against the flu each year

Cardiovascular disease was the leading cause of death in Florida in 2005, accounting for approximately 35 percent of all deaths in the state. People with heart disease are at a high risk for serious and potentially life-threatening complications from the flu.

22 Oct 2009

Women more likely than men to curb swine flu

A new American Red Cross poll shows that while concerns about exposure to the H1N1 (swine flu) virus remain high, women are more likely than men to make extra efforts to cover coughs and sneezes with tissue, wash their hands more carefully and use hand sanitizer more often.

22 Oct 2009

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).

21 Oct 2009

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

The Swine Flu (H1N1)Vaccine is starting to arrive at health departments, hospitals, and community vaccinator facilities.

21 Oct 2009

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.

21 Oct 2009

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Aethlon Medical, Inc. announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream.

21 Oct 2009

APHA urges Americans to be prepared for any kind of emergency

Setting the clocks on Nov. 1 because of daylight saving time gives us a little extra time to think about preparing for emergencies. Since Mother Nature is known to throw us a curveball when we least expect it, the American Public Health Association is urging Americans to be ready for any kind of emergency such as blizzards, floods, blackouts or influenza.

21 Oct 2009

MUSC launches Social Media Newsroom for real-time information on medical news and research

As the editorial landscape continues to evolve with the emergence of social media, many people struggle to find trusted resources that offer accurate, real time information related to healthcare news and research.

21 Oct 2009

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for GlaxoSmithKline, Sanofi-Aventis, Novartis, Baxter International, Roche Holding and several others.

21 Oct 2009

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Practice Fusion Inc. (www.practicefusion.com), the free, web-based electronic health record (EHR) for physicians, today implemented a first-of-its-kind tool that allows its physician-users to immediately and accurately identify all Tier 1 candidates for H1N1 vaccination from their patient populations using criteria published by the Centers for Disease Control and Prevention (CDC).

21 Oct 2009

Flu News and Research

Notificateur communications tool: Preventive measure for influenza A virus

Some hospital revenues could decline if H1N1 becomes pandemic

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

Majority of allergy patients can be vaccinated against swine flu after evaluation by an allergist

45% of American adults not inclined to get vaccinated against seasonal flu

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

eHealthInsurance releases answers for FAQs on swine flu and their health insurance

“Sid the Science Kid” show to explain the science behind flu vaccinations

Awareness campaign to educate families on H1N1 flu virus, seasonal flu and common cold

FDA uses Wolters Kluwer Pharma Solutions' prescription data for tracking viral treatments

CDC urges heart disease patients get vaccinated against the flu each year

Women more likely than men to curb swine flu

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

APHA urges Americans to be prepared for any kind of emergency

MUSC launches Social Media Newsroom for real-time information on medical news and research

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News